Purposeful
The AI engine Fit Assessment
BetaPurposeful effectively leverages machine learning and pattern discovery to expand therapeutics through drug repurposing, maximizing the potential of existing drugs.
Blurb
Purposeful discovers alternative effects for existing drugs using its advanced computational workflow.
HQ Location
Athens (Greece)
Founded
2018
Employees
1 - 10
Total funding raised
$200.00K
Funding Status
Pre-Seed, $200.00K, October 18, 2018
Subspaces
- Drug Repurposing
Purposeful discovers new treatments and develops pharmaceutical products for rare diseases by repurposing previously marketed drugs. Their vision is to fully utilize AI repurposing and revisit rare and common diseases to reverse disease phenotypes. It collaborates with FRAXA and FRAXA-DVI to identify drug repurposing candidates for Fragile X Syndrome. They also identify drug repurposing candidates for Glioblastoma.